3.0.0 6433 2023-03-22T18:24:49Z 2023-03-22T18:24:49Z House H HR 2012-09-19 112 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. UPTON:H.R. 6433.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 of the United StatesConstitution.[Page H6151]]]> hsif00 Energy and Commerce Committee House Standing Discharged from 2012-09-20T00:50:00Z Referred to 2012-09-20T00:48:41Z 2012-10-05 Became Public Law No: 112-193. President E40000 2 House floor actions 2012-10-05 Became Public Law No: 112-193. BecameLaw 36000 9 Library of Congress 2012-10-05 Signed by President. President E30000 2 House floor actions 2012-10-05 Signed by President. BecameLaw 36000 9 Library of Congress 2012-09-25 Presented to President. Floor E20000 2 House floor actions 2012-09-25 Presented to President. President 28000 9 Library of Congress 2012-09-24 Senate Message on Senate action sent to the House. Floor 2012-09-22 Senate Passed Senate without amendment by Unanimous Consent. (consideration: CR 9/21/2012 S6671) Floor 2012-09-22 Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR 9/21/2012 S6671) Floor 17000 9 Library of Congress 2012-09-20 Senate Received in the Senate, read twice. IntroReferral 2012-09-19 20:50:17 Motion to reconsider laid on the table Agreed to without objection. Floor H38310 2 House floor actions 2012-09-19 20:50:16 On passage Passed without objection. (text: CR H6137-6138) Floor H37100 2 House floor actions 2012-09-19 20:50:16 Passed/agreed to in House: On passage Passed without objection.(text: CR H6137-6138) Floor 8000 9 Library of Congress 2012-09-19 20:50:01 Considered by unanimous consent. (consideration: CR H6137-6138) Floor H30000 2 House floor actions 2012-09-19 20:50:00 Mr. Upton asked unanimous consent to discharge from committee and consider. Floor H30200 2 House floor actions 2012-09-19 Committee on Energy and Commerce discharged. Discharge H12300 2 House floor actions hsif00 Energy and Commerce Committee 2012-09-19 Committee on Energy and Commerce discharged. Committee 5500 9 Library of Congress hsif00 Energy and Commerce Committee 2012-09-19 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2012-09-19 Introduced in House IntroReferral Intro-H 9 Library of Congress 2012-09-19 Introduced in House IntroReferral 1000 9 Library of Congress U000031 Rep. Upton, Fred [R-MI-6] FRED UPTON R MI 6 N W000215 Rep. Waxman, Henry A. [D-CA-30] HENRY WAXMAN D CA A. 30 2012-09-19 True Public Law 112-193 Health Appropriations Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Food and Drug Administration (FDA) Prescription drugs User charges and fees Health 00 2012-09-19 Introduced in House 2012-11-09T16:53:19Z FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs.

Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.

]]> 49 2012-10-05 Public Law 2012-11-09T16:54:11Z (This measure has not been amended since it was introduced. The summary of that version is repeated here.)

FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs.

Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.

]]> FDA User Fee Corrections Act of 2012 Short Titles as Passed House FDA User Fee Corrections Act of 2012 H House Short Titles as Passed Senate FDA User Fee Corrections Act of 2012 S Senate Short Titles as Enacted FDA User Fee Corrections Act of 2012 Display Title FDA User Fee Corrections Act of 2012 Official Title as Introduced To make corrections with respect to Food and Drug Administration user fees. Enrolled Bill https://www.govinfo.gov/content/pkg/BILLS-112hr6433enr/xml/BILLS-112hr6433enr.xml Received in Senate 2012-09-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr6433rds/xml/BILLS-112hr6433rds.xml Engrossed in House 2012-09-19T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr6433eh/xml/BILLS-112hr6433eh.xml 2012-10-06T03:59:59Z Public Law 2012-10-05 Became Public Law No: 112-193. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.